Mechanisms of pituitary tumorigenesis;Mécanismes de tumorigenèse hypophysaire

Presse Medicale

Volumn 38, Issue 1, 2009, Pages 76-83

  Acunzo, Julie ^a   Saveanu, Alexandru ^a,b   Gérard, Corinne ^a   Enjalbert, Alain ^a,b   Barlier, Anne ^a,b  

^a University of Mediterranée   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; SECURIN;

CARCINOGENESIS; GENE EXPRESSION; GENE MUTATION; HYPOPHYSIS TUMOR; ONCOGENE; SHORT SURVEY;

ADENOMA; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASM PROTEINS; PITUITARY NEOPLASMS; PROMOTER REGIONS, GENETIC; TRANS-ACTIVATORS;

EID: 58049191405     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.09.005     Document Type: Short Survey

References (30)

1. Pei L., Melmed S., Scheithauer B., Kovacs K., and Prager D. H-ras mutations in human pituitary carcinoma metastases. J Clin Endocrinol Metab 78 (1994) 842-846
2. Heaney A.P. Pituitary tumour pathogenesis. Br Med Bull 75-76 (2005) 81-97
3. Levy A., and Lightman S. Molecular defects in the pathogenesis of pituitary tumours. Front Neuroendocrinol 24 (2003) 94-127
4. Weinstein L.S., Yu S., Warner D.R., and Liu J. Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr Rev 22 (2001) 675-705
5. Ballare E., Mantovani S., Lania A., Di Blasio A.M., Vallar L., and Spada A. Activating mutations of the Gs alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors. J Clin Endocrinol Metab 83 (1998) 4386-4390
6. Barlier A., Gunz G., Zamora A.J., Morange-Ramos I., Figarella-Branger D., Dufour H., et al. Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas. J Clin Endocrinol Metab 83 (1998) 1604-1610
7. Lania A., Persani L., Ballare E., Mantovani S., Losa M., and Spada A. Constitutively active Gs alpha is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas. J Clin Endocrinol Metab 83 (1998) 1624-1628
8. Barlier A., Pellegrini-Bouiller I., Gunz G., Zamora A.J., Jaquet P., and Enjalbert A. Impact of gsp oncogene on the expression of genes coding for Gsalpha, Pit-1, Gi2alpha, and somatostatin receptor 2 in human somatotroph adenomas: involvement in octreotide sensitivity. J Clin Endocrinol Metab 84 (1999) 2759-2765
9. Romano D., Magalon K., Pertuit M., Rasolonjanahary R., Barlier A., Enjalbert A., et al. Conditional overexpression of the wild-type Gs alpha as the gsp oncogene initiates chronic extracellularly regulated kinase 1/2 activation and hormone hypersecretion in pituitary cell lines. Endocrinology 148 (2007) 2973-2983
10. Zhang X., Horwitz G.A., Prezant T.R., Valentini A., Nakashima M., Bronstein M.D., et al. Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol Endocrinol 13 (1999) 156-166
11. Filippella M., Galland F., Kujas M., Young J., Faggiano A., Lombardi G., et al. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study. Clin Endocrinol (Oxf) 65 (2006) 536-543
12. Abbud R.A., Takumi I., Barker E.M., Ren S.G., Chen D.Y., Wawrowsky K., et al. Early multipotential pituitary focal hyperplasia in the alpha-subunit of glycoprotein hormone-driven pituitary tumor-transforming gene transgenic mice. Mol Endocrinol 19 (2005) 1383-1391
13. Zhuang Z., Ezzat S.Z., Vortmeyer A.O., Weil R., Oldfield Eh, Park Ws, et al. Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res 57 (1997) 5446-5451
14. Jorge B.H., Agarwal S.K., Lando V.S., Salvatori R., Barbero R.R., Abelin N., et al. Study of the multiple endocrine neoplasia type 1, growth hormone-releasing hormone receptor, Gs alpha, and Gi2 alpha genes in isolated familial acromegaly. J Clin Endocrinol Metab 86 (2001) 542-544
15. Asa S.L., Somers K., and Ezzat S. The MEN-1 gene is rarely down-regulated in pituitary adenomas. J Clin Endocrinol Metab 83 (1998) 3210-3212
16. Lania A.G., Mantovani G., Ferrero S., Pellegrini C., Bondioni S., Peverelli E., et al. Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein. Cancer Res 64 (2004) 9193-9198
17. Soares B.S., Eguchi K., and Frohman L.A. Tumor deletion mapping on chromosome 11q13 in eight families with isolated familial somatotropinoma and in 15 sporadic somatotropinomas. J Clin Endocrinol Metab 90 (2005) 6580-6587
18. Daly A.F., Rixhon M., Adam C., Dempegioti A., Tichomirowa M.A., and Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91 (2006) 4769-4775
19. Vierimaa O., Georgitsi M., Lehtonen R., Vahteristo P., Kokko A., Raitila A., et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312 (2006) 1228-1230
20. Bolger G.B., Peden A.H., Steele M.R., Mackenzie C., McEwan D.G., Wallace D.A., et al. Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2. J Biol Chem 278 (2003) 33351-33363
21. Leontiou C.A., Gueorguiev M., Van Der Spuy J., Quinton R., Lolli F., Hassan S., et al. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab 93 (2008) 2390-2401
22. Barlier A., Vanbellinghen J.F., Daly A.F., Silvy M., Jaffrain-Rea M.L., Trouillas J., et al. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. J Clin Endocrinol Metab 92 (2007) 1952-1955
23. Fero M.L., Rivkin M., Tasch M., Porter P., Carow C.E., Firpo E., et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85 (1996) 733-744
24. Nakayama K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85 (1996) 707-720
25. Pellegata N.S., Quintanilla-Martinez L., Siggelkow H., Samson E., Bink K., Hofler H., et al. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci U S A 103 (2006) 15558-15563
26. Georgitsi M., Raitila A., Karhu A., Van Der Luijt R.B., Aalfs C.M., Sane T., et al. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 92 (2007) 3321-3325
27. Farrell W.E. Epigenetic mechanisms of tumorigenesis. Horm Metab Res 37 (2005) 361-368
28. Simpson D.J., Bicknell J.E., McNicol A.M., Clayton R.N., and Farrell W.E. Hypermethylation of the p16/CDKN2A/MTSI gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas. Genes Chromosomes Cancer 24 (1999) 328-336
29. Hayward B.E., Barlier A., Korbonits M., Grossman A.B., Jacquet P., Enjalbert A., et al. Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly. J Clin Invest 107 (2001) R31-R36
30. Picard C., Silvy M., Gerard C., Buffat C., Lavaque E., Figarella-Branger D., et al. Gs alpha overexpression and loss of Gs alpha imprinting in human somatotroph adenomas: association with tumor size and response to pharmacologic treatment. Int J Cancer 121 (2007) 1245-1252